Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.34188 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.34601 | 54 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.32803 | 54 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.32463 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.29831 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.38427 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.3675 | 53 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.30718 | 53 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.33828 | 55 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.33739 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.33387 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.33588 | 55 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.33489 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.34005 | 54 |